CBD photosynthesis phenotype, a mainly Indica variety for medicinal use, high in CBD content. Regarding the production, there are not many differences with the feminized version, it is differentiated more by its physical less narcotic effect. Its aroma continues to be very sweet and pleasant; its flowers are compact but less crystalline than in its other versions. Crossed with our variety of high CBD content, it has a ratio of 1/1.
Strain FAQ
Do high-yielding strains resist pests and diseases?
On the one hand it is known that their increased biomass makes them vulnerable to pests and illnesses. However, on the other hand, breeding has enhanced their genetic resistance. New strains are being created all the time that promise high yields as well as good disease and pest resistance.
How have strains from various places optimised THC and CBD?
With a progressive approach to cannabis legalisation and research, North America and Canada have developed recreational strains with high THC and medical strains with high CBD. The legal diversity in these regions has spurred substantial breeding programmes to optimise cannabinoid content for varied uses.
Where do high CBD strains stand legally?
The legality of high CBD strains can be confusing. Local restrictions differ, with some favouring strains with a specified CBD-to-THC ratio. Most commonly there is a maximum allowed THC percentage of something like 0.2% and as long as the strain does not produce more than this, it is seen as legal. This patchwork of restrictions is creating a confusing but promising CBD-rich product industry.
Do these strains' different lineages affect their traits?
Middle of September seeds often have indica, sativa, and ruderalis genes. Indica genes provide these plants strength and compactness, sativa genes boost flavours and effects, and ruderalis genes may introduce auto-flowering features, making them adaptable to different methods.
Rare cannabis cannabinoids: what are their benefits?
Cannabis contains approximately 100 cannabinoids, including CBG and CBN, which are being studied for their reported therapeutic properties. CBG-rich strains are being studied for treating inflammatory bowel disease and glaucoma, demonstrating the vast medicinal potential of cannabis beyond just THC and CBD.